Private Advisor Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Private Advisor Group’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-547	Closed	-$10K	–	3916
2020 Q2	$10K	Buy	+547	New	+$7.61K	﹤0.01%	2954

Private Advisor Group's PTLA Position: Q3 2020 in Review

Private Advisor Group sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 547 shares — an estimated $10K sold.

Private Advisor Group first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $10K in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Private Advisor Group reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Private Advisor Group sold 547 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $10K.
Private Advisor Group first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
Private Advisor Group's Portola Pharmaceuticals, Inc. position peaked at $10K in Q2 2020.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.